Northwest Biotherapeutics Inc (NWBO)
0.485
+0.01
(+1.68%)
USD |
OTCM |
Apr 26, 16:00
Northwest Biotherapeutics Max Drawdown (5Y): 98.85% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 98.85% |
February 29, 2024 | 98.85% |
January 31, 2024 | 98.85% |
December 31, 2023 | 98.85% |
November 30, 2023 | 98.85% |
October 31, 2023 | 98.85% |
September 30, 2023 | 98.85% |
August 31, 2023 | 98.85% |
July 31, 2023 | 98.85% |
June 30, 2023 | 98.85% |
May 31, 2023 | 98.85% |
April 30, 2023 | 98.85% |
March 31, 2023 | 98.85% |
February 28, 2023 | 98.85% |
January 31, 2023 | 98.85% |
December 31, 2022 | 98.85% |
November 30, 2022 | 98.85% |
October 31, 2022 | 98.85% |
September 30, 2022 | 98.85% |
August 31, 2022 | 98.85% |
July 31, 2022 | 98.85% |
June 30, 2022 | 98.85% |
May 31, 2022 | 98.85% |
April 30, 2022 | 98.85% |
March 31, 2022 | 98.85% |
Date | Value |
---|---|
February 28, 2022 | 98.85% |
January 31, 2022 | 98.85% |
December 31, 2021 | 98.85% |
November 30, 2021 | 98.85% |
October 31, 2021 | 98.85% |
September 30, 2021 | 98.85% |
August 31, 2021 | 98.85% |
July 31, 2021 | 98.85% |
June 30, 2021 | 98.85% |
May 31, 2021 | 98.85% |
April 30, 2021 | 98.85% |
March 31, 2021 | 98.85% |
February 28, 2021 | 98.85% |
January 31, 2021 | 98.85% |
December 31, 2020 | 98.85% |
November 30, 2020 | 98.85% |
October 31, 2020 | 98.85% |
September 30, 2020 | 98.85% |
August 31, 2020 | 98.85% |
July 31, 2020 | 98.85% |
June 30, 2020 | 98.85% |
May 31, 2020 | 98.85% |
April 30, 2020 | 98.85% |
March 31, 2020 | 98.85% |
February 29, 2020 | 98.84% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.84%
Minimum
Apr 2019
98.85%
Maximum
Mar 2020
98.85%
Average
98.85%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.90% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 20.73 |
Beta (5Y) | -0.6841 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.8% |
Historical Sharpe Ratio (5Y) | 0.1094 |
Historical Sortino (5Y) | 0.3663 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.93% |